Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

The FDA will require Moderna and Pfizer to add warnings to their COVID-19 vaccine labels about myocarditis and pericarditis in young men.

In the wake of recent warnings from the Food and Drug Administration (FDA), about half of Americans think vaccines against ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

The FDA is also expanding its warning that some vaccines are linked to a risk of heart inflammation in young men.

After a spring lull, experts are warning that cases will likely rise again ... Drugmaker Moderna announced that the FDA had approved its lower-dose COVID-19 vaccine for adults 65 and older, and people ...

The shot is also cleared for individuals between 12 and 64 years of age who are at least one risk factor as defined by the ...

Senate panel is trying to determine why the feds delayed telling doctors for months about heart-inflammation risks from COVID ...

The Food and Drug Administration ... also includes an updated warning regarding the increased risk of myocarditis and pericarditis with mRNA COVID-19 vaccines. The mNexspike vaccine is supplied ...